EN
HI
Summary
As of 26 Oct, 2026, Neuland Laboratories stock price is ₹18865. During the trading session, the stock has moved between an intraday low of ₹18120.00 and an intraday high of ₹19050.00. Over the last 52 weeks, Neuland Laboratories has traded between ₹11500.00 and ₹24225.00.
The stock has recorded a trading volume of 53,347 shares,. Its Average Traded Price (ATP) is ₹18645.65, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹18865.00.
Neuland Laboratories has an upper circuit limit of ₹22635.00 and a lower circuit limit of ₹15095.00. The total value traded stands at ₹99.47 CR, and the delivery percentage for the day is 48.34%.
The stock is currently traded with a market lot size of 1. Neuland Laboratories also offers a dividend yield of 0.18%.
Neuland Laboratories Share Price Chart
Neuland Laboratories Share Key Metrics
Volume
53347.00
Market Cap
24203.59 CR
LTQ@LTP
1@18865.00
ATP
18645.65
Var Margin
20.42 %
Circuit Range
15095-22635
Delivery %
48.34 %
Value
99.47 CR
ASM/GSM
No
Market Lot
1
Neuland Laboratories Fundamentals
P/E Ratio
48.78
P/B Ratio
12.01
Div. Yield
0.18
Sector P/E
37.75
Sector P/B
3.1
Sec. Div. Yield
0.54
Neuland Laboratories Resistance and Support
Pivot 18678.33
Resistance
First Resistance
19236.66
Second Resistance
19608.33
Third Resistance
20166.66
Support
First Support
18306.66
Second Support
17748.33
Third Support
17376.66
Neuland Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 23 2026 | 19020 | 18865 | -0.37% | 19050 | 18120 |
| Thu Oct 22 2026 | 18985 | 18935 | -0.21% | 19125 | 18530 |
| Wed Oct 21 2026 | 19220 | 18975 | -1.27% | 19380 | 18500 |
Neuland Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-02-10 | Quarterly Results |
| 2024-11-06 | Quarterly Results |
Neuland Laboratories News
Neuland Laboratories Ltd - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026
Neuland Laboratories' board of directors will meet on November 3, 2026. The primary agenda is to approve the financial results for the quarter ended September 30, 2026.
Oct 22 2026 17:20:55
Neuland Laboratories Ltd - 524558 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Neuland Laboratories received the Establishment Inspection Report (EIR) from the US FDA for its Unit 3 manufacturing facility in Gaddapotharam. The US FDA has officially closed the inspection conducted between August 10 and 14, 2026.
Oct 14 2026 21:43:19
Neuland Laboratories Management
| Name | Position |
|---|---|
| Davuluri Rama Mohan Rao | Chairman |
| Davuluri Sucheth Rao | Vice Chairman |
Neuland Laboratories Similar Stocks
Wockhardt Ltd.
1801.70
0.00 (0.00%)
Sai Life Sciences Ltd.
1395.30
0.00 (0.00%)
Krishna Institute of Medical Sciences Ltd
665.15
0.00 (0.00%)
Acutaas Chemicals Ltd.
3137.70
0.00 (0.00%)
Piramal Pharma Ltd.
191.07
0.00 (0.00%)
Rubicon Research Ltd.
1424.40
0.00 (0.00%)
Granules India Ltd.
794.75
0.00 (0.00%)
Astrazeneca Pharma India Ltd.
5988.50
0.00 (0.00%)
Cohance Lifesciences Ltd.
449.85
0.00 (0.00%)
Caplin Point Laboratories Ltd.
2222.00
0.00 (0.00%)
Neuland Laboratories FAQs
The Buying Price of Neuland Laboratories share is 18865 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Neuland Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Neuland Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Neuland Laboratories shares is 48.78. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Neuland Laboratories shares is 12.01. Useful to assess the stock's value relative to its book value.
To assess Neuland Laboratories’s valuation compare Sector P/E, P/B which are 37.75 & 3.1 with sector averages, along with growth rates and financial metrics.
The Market Cap of Neuland Laboratories is 24203.59 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Neuland Laboratories share price is 24225.00 & 11500.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Neuland Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NEULANDLAB
Or Download Choice FinX App
Invest in NEULANDLAB
